
Loading, please wait...

Loading, please wait...

The HubBLe randomized trial compared haemorrhoidal artery ligation with rubber band ligation for symptomatic second- and third-degree haemorrhoids. The study is useful because both techniques are designed to avoid conventional excisional haemorrhoidectomy, yet they differ in invasiveness, recurrence profile, postoperative discomfort and resource requirements. The trial found that both approaches were effective, but they did not offer identical trade-offs. Rubber band ligation remained a simple and relatively inexpensive outpatient option, while haemorrhoidal artery ligation involved a more procedural approach with different patterns of recurrence and postoperative experience. For surgeons, the key lesson is that “less invasive” does not automatically mean “better” across every endpoint. Treatment choice should consider haemorrhoid grade, symptom pattern, patient expectations, recurrence tolerance, availability of anaesthesia and local expertise. The evidence also supports a step-up philosophy in proctology: the simplest effective intervention should often be considered first, with more invasive options reserved for patients who need them. HubBLe is particularly relevant to the ASICON proctology focus because it demonstrates how comparative trials can help surgeons choose between modern minimally invasive treatments rather than relying solely on technical preference or habit.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The HubBLe randomized trial compared haemorrhoidal artery ligation with rubber band ligation for symptomatic second- and third-degree haemorrhoids. The study is useful because both techniques are designed to avoid conventional excisional haemorrhoidectomy, yet they differ in invasiveness, recurrence profile, postoperative discomfort and resource requirements. The trial found that both approaches were effective, but they did not offer identical trade-offs. Rubber band ligation remained a simple and relatively inexpensive outpatient option, while haemorrhoidal artery ligation involved a more procedural approach with different patterns of recurrence and postoperative experience. For surgeons, the key lesson is that “less invasive” does not automatically mean “better” across every endpoint. Treatment choice should consider haemorrhoid grade, symptom pattern, patient expectations, recurrence tolerance, availability of anaesthesia and local expertise. The evidence also supports a step-up philosophy in proctology: the simplest effective intervention should often be considered first, with more invasive options reserved for patients who need them. HubBLe is particularly relevant to the ASICON proctology focus because it demonstrates how comparative trials can help surgeons choose between modern minimally invasive treatments rather than relying solely on technical preference or habit.
4 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back